Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.

Naresh A, Long W, Vidal GA, Wimley WC, Marrero L, Sartor CI, Tovey S, Cooke TG, Bartlett JM, Jones FE.

Cancer Res. 2006 Jun 15;66(12):6412-20.

2.
3.

Mechanisms of cytochrome c release by proapoptotic BCL-2 family members.

Scorrano L, Korsmeyer SJ.

Biochem Biophys Res Commun. 2003 May 9;304(3):437-44. Review.

PMID:
12729577
4.

Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway.

Wong WW, Puthalakath H.

IUBMB Life. 2008 Jun;60(6):390-7. doi: 10.1002/iub.51. Review.

5.

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH.

Cell Death Differ. 2000 Dec;7(12):1166-73. Review.

6.

HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.

Jones FE.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):247-58. doi: 10.1007/s10911-008-9076-6. Epub 2008 May 13. Review.

7.

BH3-only proteins in apoptosis and beyond: an overview.

Lomonosova E, Chinnadurai G.

Oncogene. 2008 Dec;27 Suppl 1:S2-19. doi: 10.1038/onc.2009.39. Review.

8.

Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective.

Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB.

Mol Cancer Res. 2008 Jun;6(6):885-91. doi: 10.1158/1541-7786.MCR-07-0369. Review.

9.

BH3-only proteins: a 20-year stock-take.

Doerflinger M, Glab JA, Puthalakath H.

FEBS J. 2015 Mar;282(6):1006-16. doi: 10.1111/febs.13190. Epub 2015 Jan 26. Review.

10.

BH3-only proteins: Orchestrators of apoptosis.

Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW.

Biochim Biophys Acta. 2011 Apr;1813(4):508-20. doi: 10.1016/j.bbamcr.2010.11.024. Epub 2010 Dec 10. Review.

11.

Desensitization by different strategies of epidermal growth factor receptor and ErbB4.

Yamamoto H, Higa-Nakamine S, Noguchi N, Maeda N, Kondo Y, Toku S, Kukita I, Sugahara K.

J Pharmacol Sci. 2014;124(3):287-93. Epub 2014 Feb 19. Review.

12.

BAD: undertaker by night, candyman by day.

Danial NN.

Oncogene. 2008 Dec;27 Suppl 1:S53-70. doi: 10.1038/onc.2009.44. Review.

PMID:
19641507
13.

EGFR signaling in breast cancer: bad to the bone.

Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ 2nd.

Semin Cell Dev Biol. 2010 Dec;21(9):951-60. doi: 10.1016/j.semcdb.2010.08.009. Epub 2010 Sep 9. Review.

14.

Noxa: at the tip of the balance between life and death.

Ploner C, Kofler R, Villunger A.

Oncogene. 2008 Dec;27 Suppl 1:S84-92. doi: 10.1038/onc.2009.46. Review.

15.

BH3-only proteins and their effects on cancer.

Vo TT, Letai A.

Adv Exp Med Biol. 2010;687:49-63. Review.

16.

[BH3 mimetics as a strategy to complement anticancer therapies].

Hartman MŁ, Czyż M.

Postepy Hig Med Dosw (Online). 2012 Feb 3;66:67-77. Review. Polish.

17.

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS 3rd.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):235-46. doi: 10.1007/s10911-008-9080-x. Epub 2008 Apr 25. Review.

18.

Mitochondrial signaling in cell death via the Bcl-2 family.

Leibowitz B, Yu J.

Cancer Biol Ther. 2010 Mar 15;9(6):417-22. Epub 2010 Mar 3. Review.

Supplemental Content

Support Center